To help patients achieve weight loss success and improve clinical outcomes, health care providers must understand the factors that inform patient decisions regarding obesity treatment.

 

As with most chronic conditions, the range of obesity treatments can feel overwhelming: dietary changes, exercise programs, weight loss medications, and bariatric surgery. Guidance that sounds straightforward — such as adopting a plant-forward pattern, limiting red meat, switching to pescatarian eating, or trying intermittent fasting — can still leave patients stuck between options. In practice, treatment selection is seldom linear, because every approach involves trade-offs and uncertainties.

 

Obesity treatment decisions hinge on individual factors: preferences, prior experiences, concerns, beliefs, and the quality of information patients have. Practical issues — cost, access, and tolerability — add another layer and vary widely from person to person. To support patients effectively, clinicians should explore these influences alongside clinical evidence, aligning options with the patient’s goals and life context. Involving patients in the decision process honors autonomy and is linked to better engagement and outcomes.

 

Factors That Inform Patients’ Obesity Treatment Decisions

A 2024¹ qualitative study (n=10) using a participatory action research design examined patients’ preferences for obesity treatment. Participants (8 women, 2 men), ages 18–75, had BMI ≥35 kg/m² and comorbidities such as type 2 diabetes, hypertension, chronic kidney disease, or metabolic dysfunction–associated steatotic liver disease. Each participant submitted 12–27 photographs to illustrate why they might choose one treatment over another — their concerns, hopes, and lived experience—and researchers conducted semi-structured interviews to deepen the analysis.

 

Results

• 50 percent of participants selected nutrition- and exercise-based treatments because they believed these were more sustainable and would help with overall health and psychological well-being. Among this set, some expressed concerns about medications and associated side effects.
• 30 percent selected medications because they believed they would help with comorbidities, noting this could allay fears for future health and improve overall well-being.
• 20 percent would opt for surgery because they viewed this as a “one-and-done” option. Participants who selected surgery believed the results were more immediate.

 

Themes

Following the semi-structured interviews, five themes emerged:

1. Accessibility emerged as a primary factor in treatment selection. Participants noted financial and insurance barriers for GLP-1 medications and long waitlists for surgery; some reported that their health care providers suggested going overseas to avoid delays. Patients opting for nutrition- and exercise-based approaches also mentioned cost. The authors emphasize considering not only clinical suitability but also the practicality of patients’ access to obesity treatments.
2. Polypharmacy was a concern, particularly among patients already taking medications for other conditions. Participants worried about side effects from adding another drug. Those who preferred lifestyle changes or surgery expressed a desire to rely less on medications, while those favoring an obesity medication hoped that weight loss would ultimately reduce their overall medication burden.
3. Fears about future health — including progression of comorbidities, loss of independence, or disability — were common. Participants cited cardiovascular disease, mobility loss, and diabetes-related amputations as specific fears. They weighed treatment options against their perceived health trajectory: individuals more fearful of worsening comorbidities showed greater interest in medication or surgery, whereas those earlier in their disease course tended to prefer lifestyle changes.
4. Information mismanagement — from both health care providers and external sources — was another issue. Some participants felt overwhelmed by contradictory messages; others felt uninformed. Many reported seeking information from social media and other non-medical sources out of necessity. Participants who preferred medication often said they reached that conclusion after doing their own research or without consulting a health care provider. Frustration about limited discussion of surgical and pharmacologic options was also expressed.
5. Lack of support was the final theme. Participants described insufficient support from family, the health care system, and their communities. Some felt judged or dismissed by health care providers; others perceived a lack of emotional or logistical support. Participants with comorbidities or prior unsuccessful weight-loss attempts reported feeling isolated, and several worried about ridicule based on past experiences in health care settings.

This study highlights the complexities of obesity treatment decisions and their highly personal nature. Key findings suggest that patients who select lifestyle interventions tend to prioritize sustainability and autonomy as well as a desire to avoid medication. Additionally, participants who selected medications tend to be motivated by self-efficacy and accessibility. Finally, participants who preferred surgery tended to be in the midst of urgent health issues or milestones like planning a family, hence their desire for a quicker path to their weight loss goal.

Clinical Implications: Turning Patient Influences into Actionable Care Plans

Talking with patients to understand their priorities, constraints, and past experiences is essential to building a sustainable weight-loss plan. Integrating these perspectives through shared decision-making improves satisfaction and adherence — and helps align the “right” therapy to the right person. In practice, this means offering clear pathways that map to common patient influences:

• Structured meal replacement programs (e.g., Robard’s New Direction Advanced and Numetra) for patients who value predictable nutrition, portion control, and clinic support.
• GLP-1 nutrition support with Biocare for patients using anti-obesity medications who need help meeting protein targets, managing side effects, and sustaining intake.
• Pre-/peri-operative pathways using Robard’s PeriOptimization Protocol to support candidates considering bariatric surgery with evidence-aligned nutrition before and after procedures.

 

Across options, normalize obesity as a chronic disease, use simple decision aids (side-by-side comparisons, cost/access checklists), and set goals that reflect the patient’s life context (work schedule, food budget, comorbidities). Close the loop with follow-up touchpoints to troubleshoot tolerability, cost, or access—so the plan remains both clinically sound and personally workable.

Source(s):

1 What influences patient decisions when selecting an obesity treatment?

 

About the Author: Dr. Dawn M. Sweet has over 20 years of experience in the field of communication. Dr. Sweet has given several invited talks to and workshops for academic and private sector audiences on the role of nonverbal and verbal communication in achieving positive outcomes and mitigating bias. Her research has been published in several top ranked peer-review journals, and it has been featured on NPR’s River to River / All Things Considered, Buzzfeed, and Science Daily. Her research has also been used to inform expert testimony.

About Robard: Robard Corporation’s medical obesity treatment programs and scientifically-designed nutrition products have been utilized by physicians, surgeons and hospitals across the United States to successfully treat patients living with obesity. To learn more about us and how we can help your practice and patients, visit us online www.Robard.com, email us at info@robard.com, or call (800) 222-9201.